Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivien Hébert

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Dermatology|July 19, 2023
Major improvement of very severe alopecia areata in patients treated with the combination of baricitinib and low doses of corticosteroids: an eight-case seriesVivien Hébert, Pascal Joly
La Revue Du Praticien|December 5, 2018
Bullous pemphigoid, a dermatosis of the elderlyVivien Hébert, Pascal Joly
Melanoma Research|September 20, 2022
Successful use of rituximab for refractory hemophagocytic lymphohistiocytosis in a melanoma patient treated with targeted therapyInes Tejedor, Billal Tedbirt, Priscille Carvalho, et al.
Clinical Case Reports|October 22, 2020
Agranulocytosis-complicated DRESS with medullar HHV-6 replicationMargot Lehericey, Florence Tétart, Priscille Carvalho, et al.
Frontiers in Immunology|April 3, 2023
Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 casesRaphaël Janela, Norito Ishii, Marion Castel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 7, 2026
Incidence of P200 pemphigoid: A nationwide studyFabienne Jouen, Marion Carrette, Marie-Laure Golinski, et al.
JAMA Dermatology|June 22, 2022
Evaluation of Clinical Relevance and Biological Effects of Antirituximab Antibodies in Patients With PemphigusAlexandre Lemieux, Maud Maho-Vaillant, Marie-Laure Golinski, et al.
BMC Nephrology|October 13, 2019
Ipilimumab-induced renal granulomatous arteritis: a case reportMathilde Lemoine, Baptiste Dilly, Alexandre Curie, et al.
Frontiers in Immunology|May 31, 2021
Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid RegimenVivien Hébert, Maud Maho-Vaillant, Marie-Laure Golinski, et al.
The British Journal of Dermatology|June 7, 2024
The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgarisVivien Hébert, Julien Novarino, Maud Maho-Vaillant, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Dermatology|July 19, 2023
Major improvement of very severe alopecia areata in patients treated with the combination of baricitinib and low doses of corticosteroids: an eight-case seriesVivien Hébert, Pascal Joly
La Revue Du Praticien|December 5, 2018
Bullous pemphigoid, a dermatosis of the elderlyVivien Hébert, Pascal Joly
Melanoma Research|September 20, 2022
Successful use of rituximab for refractory hemophagocytic lymphohistiocytosis in a melanoma patient treated with targeted therapyInes Tejedor, Billal Tedbirt, Priscille Carvalho, et al.
Clinical Case Reports|October 22, 2020
Agranulocytosis-complicated DRESS with medullar HHV-6 replicationMargot Lehericey, Florence Tétart, Priscille Carvalho, et al.
Frontiers in Immunology|April 3, 2023
Mixed muco-cutaneous pemphigoid: Clinical and immunological features of 15 casesRaphaël Janela, Norito Ishii, Marion Castel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 7, 2026
Incidence of P200 pemphigoid: A nationwide studyFabienne Jouen, Marion Carrette, Marie-Laure Golinski, et al.
JAMA Dermatology|June 22, 2022
Evaluation of Clinical Relevance and Biological Effects of Antirituximab Antibodies in Patients With PemphigusAlexandre Lemieux, Maud Maho-Vaillant, Marie-Laure Golinski, et al.
BMC Nephrology|October 13, 2019
Ipilimumab-induced renal granulomatous arteritis: a case reportMathilde Lemoine, Baptiste Dilly, Alexandre Curie, et al.
Frontiers in Immunology|May 31, 2021
Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid RegimenVivien Hébert, Maud Maho-Vaillant, Marie-Laure Golinski, et al.
The British Journal of Dermatology|June 7, 2024
The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgarisVivien Hébert, Julien Novarino, Maud Maho-Vaillant, et al.
Pageof 3